ATE123577T1 - Vaginale probe, test und reagenzien. - Google Patents

Vaginale probe, test und reagenzien.

Info

Publication number
ATE123577T1
ATE123577T1 AT88119147T AT88119147T ATE123577T1 AT E123577 T1 ATE123577 T1 AT E123577T1 AT 88119147 T AT88119147 T AT 88119147T AT 88119147 T AT88119147 T AT 88119147T AT E123577 T1 ATE123577 T1 AT E123577T1
Authority
AT
Austria
Prior art keywords
reagents
test
vaginal sample
kits
pregnancy
Prior art date
Application number
AT88119147T
Other languages
English (en)
Inventor
Nelson N H Teng
Andrew E Senyei
Original Assignee
Adeza Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/244,969 external-priority patent/US5096830A/en
Application filed by Adeza Biomedical Corp filed Critical Adeza Biomedical Corp
Application granted granted Critical
Publication of ATE123577T1 publication Critical patent/ATE123577T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT88119147T 1987-11-17 1988-11-17 Vaginale probe, test und reagenzien. ATE123577T1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US12189987A 1987-11-17 1987-11-17
US12189587A 1987-11-17 1987-11-17
US12190287A 1987-11-17 1987-11-17
US12189487A 1987-11-17 1987-11-17
US12189387A 1987-11-17 1987-11-17
US12190087A 1987-11-17 1987-11-17
US07/244,969 US5096830A (en) 1987-11-17 1988-09-15 Preterm labor and membrane rupture test

Publications (1)

Publication Number Publication Date
ATE123577T1 true ATE123577T1 (de) 1995-06-15

Family

ID=27568795

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88119147T ATE123577T1 (de) 1987-11-17 1988-11-17 Vaginale probe, test und reagenzien.

Country Status (7)

Country Link
EP (1) EP0316919B1 (de)
JP (1) JP2612915B2 (de)
AT (1) ATE123577T1 (de)
CA (1) CA1337394C (de)
DE (2) DE3853940T4 (de)
ES (1) ES2074993T3 (de)
GR (1) GR3017075T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281522A (en) * 1988-09-15 1994-01-25 Adeza Biomedical Corporation Reagents and kits for determination of fetal fibronectin in a vaginal sample
AU7674591A (en) * 1990-04-12 1991-11-11 Adeza Biomedical Corporation Pregnancy induced hypertension and eclampsia immunoassay and reagents
AU1150892A (en) * 1990-12-04 1992-07-08 Mount Sinai School Of Medicine Of The City University Of New York, The Therapeutic and diagnostic applications of fetal fibronectin
FI86777C (fi) * 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid
WO1993009432A1 (en) * 1991-11-04 1993-05-13 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
DE69231636T2 (de) * 1991-11-04 2001-05-23 Adeza Biomedical Corp Screeningverfahren zur identifizierung von frauen mit erhöhtem frühgeburtsrisiko
FI94181C (fi) 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
JP3742649B2 (ja) * 1993-01-22 2006-02-08 アデザ・バイオメデイカル・コーポレイシヨン 切迫分娩についての危険にある女性における膜の破裂を決定するための検定方法
US6172198B1 (en) 1993-03-19 2001-01-09 Northern Sydney Area Health Service PAPP-A, its immunodetection and uses
US6678669B2 (en) 1996-02-09 2004-01-13 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
US6394952B1 (en) 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
DK2204654T3 (da) 2002-08-13 2013-03-11 N Dia Inc Anordninger og fremgangsmåder til detektering af fostervand i vaginalsekretioner
EP1711618B1 (de) * 2003-12-23 2010-08-04 Mount Sinai Hospital Corporation Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
EP1716419A2 (de) * 2004-02-20 2006-11-02 AplaGen GmbH Verfahren zum nachweis von autoantikörpern gegen spezifische peptide und dessen verwendung bei der diagnose und behandlung von schwangerschaftsverlust oder unfruchtbarkeit
US20060024722A1 (en) 2004-07-30 2006-02-02 Mark Fischer-Colbrie Samples for detection of oncofetal fibronectin and uses thereof
US8097317B2 (en) * 2007-01-26 2012-01-17 Toyo Seikan Kaisha, Ltd. High-gloss multilayer plastic container
GB0820999D0 (en) * 2008-11-17 2008-12-24 Menon Johansson Anatole S Pregnancy testing
CA2897053C (en) 2013-01-02 2020-10-13 N-Dia, Inc. Methods for predicting time-to-delivery in pregnant women
JP6168580B1 (ja) * 2016-02-24 2017-07-26 積水メディカル株式会社 イムノクロマトグラフィーを利用した癌胎児性フィブロネクチンの検出方法
US20190094215A1 (en) * 2016-03-31 2019-03-28 Sekisui Medical Co., Ltd. Oncofetal fibronectin detection method using simple immunoassay
US10935555B2 (en) 2016-12-22 2021-03-02 Qiagen Sciences, Llc Determining candidate for induction of labor
US10656164B2 (en) 2016-12-22 2020-05-19 Qiagen Sciences, Llc Screening asymptomatic pregnant woman for preterm birth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3171783A (en) * 1962-08-15 1965-03-02 Hyland Lab Diagnostic procedure
IL48741A (en) * 1975-12-26 1979-07-25 Rafa Labor Ltd Method for the determination of pregnancy
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
DE3603053A1 (de) * 1986-01-30 1987-08-06 Schering Ag Schwangerschaftsnachweis mit epf

Also Published As

Publication number Publication date
DE3853940T2 (de) 1995-12-14
DE3853940D1 (de) 1995-07-13
EP0316919A2 (de) 1989-05-24
GR3017075T3 (en) 1995-11-30
EP0316919A3 (en) 1990-08-16
JPH01195848A (ja) 1989-08-07
CA1337394C (en) 1995-10-24
ES2074993T3 (es) 1995-10-01
JP2612915B2 (ja) 1997-05-21
EP0316919B1 (de) 1995-06-07
DE3853940T4 (de) 2001-11-08

Similar Documents

Publication Publication Date Title
DE3853940D1 (de) Vaginale Probe, Test und Reagenzien.
ATE307338T1 (de) Immunochromatographische assay-vorrichtungen mit trennungselementen
ES2195280T3 (es) Tira de analisis de diagnostico con dispositivo de calibracion sobre la propia tira.
NO166017C (no) Fremgangsmaate og reagenskombinasjon for detektering av enspesiell nukleotidsekvens i en proeve.
IE44238L (en) Device for diagnosis of pregnancy
EP0355823A3 (de) Verfahren und Vorrichtung zur automatischen Probenanalyse
DE3485920D1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
GB2321967A (en) Opaque reaction matrix for the analysis of whole blood
ATE40217T1 (de) Bestimmungsmethode und testsatz fuer proben von vollblut.
DE69021470D1 (de) Transfervorrichtung für flüssigkeiten.
ATE117436T1 (de) Verfahren und vorrichtung gekennzeichnet durch eine nicht-saugfähige, querfluss-ermöglichende membran.
ATE100591T1 (de) Vorrichtung und verfahren zur bestimmung eines analyten.
ATE101722T1 (de) Qualitativer enzymtest zur visuellen auswertung.
ATE130437T1 (de) Immuntest und reagenzien zum nachweis von durch schwangerschaft hervorgerufenem bluthochdruck und eklampsie.
DE3686474D1 (de) Diagnostische probe.
FI71433C (fi) Apparat foer immunokemisk bestaemning
PT797097E (pt) Ensaio imunologico de particulas com matriz compacta
DK0381450T3 (da) Assay for basisk phosphatase fra knogler.
CA2117378A1 (en) Htlv-i/htlv-ii assay and method
DE69529691D1 (de) Differenziertes timingsverfahren zum nachweiss multiple analyte in eine testprobe
MY106963A (en) Agglutination assay.
JP2000180445A (ja) 検尿試薬セル及び検尿容器
FI902322A0 (fi) Diagnostinen reagenssi nivelreuman diagnosoinnissa käytettäväksi
DK563588D0 (da) Proevningsapparat til brug ved proevning for en analysand
Holt et al. Effects of IV Hydration on Levels of hCG in the Serum and Urine of Women With Possible Ectopic Pregnancy

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time